Repeated Neutron delays undermine the premium on Rocket Lab stock when execution keeps slipping. The company does not live or die by Neutron, but 50x sales was unjustified; even at 26x 2027 sales, a legitimate price suggests another 50% decline. x.com  x.com 

Rocket Lab's delayed Neutron first flight pushes out a key part of its planned launch capacity. Flight one has moved to 2027, at least 1.5 years later than the previously indicated timing; the lack of clearer guidance is frustrating. The stock could fall 50% if it breaks key support, though that downside is conditional. x.com  x.com  x.com 

Rocket Lab's Neutron delay looks like a manufacturing issue, not a flawed design. Rocket Lab says it identified and mitigated dome voids, but this second setback delays launch revenue; first flight could slip to mid-2027 or later if testing finds more issues. Space Systems is about 81% of revenue and backlog is around $2.4B, sustaining the business as Neutron develops. Rocket Lab could still become a megacap over the next decade. x.com 

Rocket Lab's government awards and backlog look priced in, while the costs of Neutron do not. Its space-beta monopoly has ended with SpaceX's listing, and it needs to max out R&D to accelerate Neutron before its maiden flight. A brand-new rocket, a new methalox engine and a new launch site burning more money mean weak earnings the market has apparently not priced. x.com  x.com 

Rocket Lab's only 'moat' was Neutron, and its reported launch delay now amounts to cancellation for the investment case. The quoted report puts its inaugural launch in 2027; $2.99 is floated as a possible share price. x.com 

Government launch contracts pulled forward by limited supply could mean big money for Rocket Lab's Neutron despite its delay. Peter Beck said Neutron demand is significant and new contracts can be discussed soon; a big announcement to offset the delay is also expected. Repeated resets of investor expectations make a rough near-term reaction partly deserved, though the long-term business remains compelling. More transparent updates would be better than overpromising and missing dates. x.com  x.com  … Show more

Rocket Lab shares look set to grind as Neutron's first flight slips, even though the core business is at its strongest. Q2 revenue hit a record $234.1M, up 62%, and backlog rose 137% to $2.356B. But the Q3 guide cuts GAAP gross margin to 29-31% from 36.1%, below the ~37.6% expected, with adjusted EBITDA losses widening to $17-23M on low-margin satellite programs, Mynaric integration and Neutron spending. A Q1 2027 Neutron debut is now the base case, which will disappoint high expectations. x.com 

Rocket Lab's Neutron delay could drag public space stocks down because the space basket usually trades together. Rocket Lab is likely to pull AST SpaceMobile down with it, especially in a bad market. The delay also pushes back a possible AST launch on Neutron, though that launch was not expected and the news is not necessarily bad for AST directly. x.com  x.com  x.com 

Rocket Lab's Neutron delay looks minor because its cadence should scale much faster than Terran-R's in the long run, even if Terran-R flies first. A forward-dome manufacturing issue moved Neutron's first flight to 2027; Q2 now sounds more likely than the expected Q1. The delay is disappointing, but Electron reached 100 launches faster than Falcon 9, and Iridium does not need Neutron soon. Peter Beck's transparency is appreciated; management may have waited for a solution despite bad timing. … Show more

Orbital data centers may take far longer than investors expect, if they happen at all. SpaceX sells compute on Earth and invests in power and cooling there, widening the hype-reality gap. SpaceX, Rocket Lab, AST SpaceMobile and Redwire could be dead money for years while the vision catches up. x.com